Clinical Trials: Find a Clinical Trial

At any time Memorial Sloan Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, the trial’s eligibility criteria, and how to get more information.

The list below includes clinical trials for adult cancers. Please visit our pediatric cancer care section to find a pediatric clinical trial.

Showing 41 - 60 of 495 trials
Titlesort icon Investigator Disease(s)
A Phase I Study of Debio1347 in Patients with Advanced Cancers Containing FGFR Alterations
[Protocol 13-131]
Voss, Martin
  • Bladder Cancer
  • Breast Cancer
  • Head & Neck Cancer
  • Lung Cancer, Non-Small Cell
    • Other
  • Lung Cancer, Small Cell
  • Solid Tumors
  • Upper Gastrointestinal
    • Gastric Cancer
  • Uterine (Endometrial) Cancer
A Phase I Study of DLYE5953A in Patients with Advanced or Persistent Solid Tumors
[Protocol 14-089]
Modi, Shanu
  • Breast Cancer
  • Head & Neck Cancer
  • Lung Cancer, Non-Small Cell
  • Ovarian Cancer
  • Upper Gastrointestinal
    • Gastric Cancer
    • Pancreatic Cancer
A Phase I Study of DS-3032B in Patients with Advanced Solid Tumors or Lymphomas
[Protocol 13-171]
Gounder, Mrinal
  • Lymphoma
  • Solid Tumors
A Phase I Study of DSTP3086S in Patients with Metastatic Castration-Resistant Prostate Cancer
[Protocol 11-016]
Danila, Daniel
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
A Phase I Study of EGF816 in Patients with Lung Cancer Containing the EGFR T790M Mutation
[Protocol 14-112]
Riely, Gregory
  • Lung Cancer, Non-Small Cell
A Phase I Study of Enzalutamide (MDV3100) in Patients with Previously Treated Metastatic Breast Cancer
[Protocol 12-155]
Traina, Tiffany
  • Breast Cancer
A Phase I Study of EPZ-5676 in Patients with Relapsed/Refractory Leukemia and Other Advanced Hematologic Cancers
[Protocol 12-181]
Tallman, Martin
  • Hematology
    • Hematologic Malignancies
    • Myelodysplastic Syndrome
  • Leukemia
    • Acute Lymphoblastic Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
    • Chronic Myelocytic Leukemia
    • Myelodysplastic Syndrome
    • Myeloproliferative Neoplasm
A Phase I Study of EPZ-5676 to Treat Children with Recurrent or Persistent MLL-Mutant Acute Leukemia
Relapsed/Refractory
[Protocol 14-080]
Shukla, Neerav
  • Leukemia
    • Acute Lymphoblastic Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
A Phase I Study of Ganetespib with Paclitaxel and Trastuzumab in Women with Metastatic Breast Cancer
[Protocol 13-168]
Modi, Shanu
  • Breast Cancer
A Phase I Study of Genetically Modified T Cells Targeting CD19 in Pediatric and Young Adult Patients with Relapsed B-Cell Acute Lymphoblastic Leukemia
Relapsed/Refractory
[Protocol 13-052]
Curran, Kevin
  • Leukemia
    • Acute Lymphoblastic Leukemia
A Phase I Study of Genetically Modified T Cells to Treat Recurrent or Refractory Chronic Lymphocytic Leukemia
[Protocol 06-138]
Park, Jae
  • Leukemia
    • Chronic Lymphocytic Leukemia
A Phase I Study of GL-ONC1 for Treating Malignant Pleural Effusion
[Protocol 12-169]
Rusch, Valerie
  • Breast Cancer
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
  • Lung Cancer, Small Cell
  • Mesothelioma
A Phase I Study of HDM201 in Patients with Advanced Cancers and a Normal TP53 Gene
[Protocol 14-139]
Hyman, David
  • Colorectal Cancer
  • Germ Cell Tumors
  • Hematology
    • Hematologic Malignancies
    • Myelodysplastic Syndrome
  • Kidney Cancer
  • Leukemia
  • Melanoma
  • Sarcomas
    • Osteosarcoma
    • Soft Tissue Sarcoma
  • Solid Tumors
A Phase I Study of Hepatic Arterial Infusion with Floxuridine, Dexamethasone, and Gemcitabine after Surgery for Liver Cholangiocarcinoma
[Protocol 13-148]
Cercek, Andrea
  • Hepatobiliary
    • Liver Cancer
A Phase I Study of High-Dose Therapy and Autologous Stem Cell Transplantation Followed by Modified T Cells for Aggressive B-Cell Non-Hodgkin Lymphoma
Relapsed/Refractory
[Protocol 12-117]
Sauter, Craig
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase I Study of High-Dose-Rate Brachytherapy plus Chemotherapy in Patients with Recurrent Rectal or Anal Cancer
Newly Diagnosed & Relapsed/Refractory
[Protocol 14-104]
Goodman, Karyn
  • Colorectal Cancer
    • Rectal Cancer
A Phase I Study of Humanized 3F8 Monoclonal Antibody in Patients with High-Risk Neuroblastoma and GD2-Positive Tumors
[Protocol 11-009]
Basu, Ellen
  • Neuroblastoma
  • Sarcomas
    • Osteosarcoma
    • Soft Tissue Sarcoma
A Phase I Study of Humanized 3F8 plus Interleukin-2 in Patients with High-Risk Neuroblastoma and GD2-Positive Tumors
Relapsed/Refractory
[Protocol 12-116]
Roberts, Stephen
  • Neuroblastoma
  • Sarcomas
    • Osteosarcoma
    • Soft Tissue Sarcoma
A Phase I Study of Hypofractionated Stereotactic Radiosurgery with Bevacizumab to Treat Recurrent Malignant Glioma
[Protocol 11-057]
Omuro, Antonio
  • Brain Tumors, Primary
  • Pediatric Brain Tumors
    • Brain Cancer
A Phase I Study of IMGN529 in Patients with Recurrent or Persistent Non-Hodgkin Lymphoma
[Protocol 13-073]
Palomba, M. Lia
  • Lymphoma
    • Non-Hodgkin's Lymphoma